MEDIVIC Trademark

Trademark Overview


On Wednesday, October 3, 2018, a trademark application was filed for MEDIVIC with the United States Patent and Trademark Office. The USPTO has given the MEDIVIC trademark a serial number of 79249332. The federal status of this trademark filing is REGISTERED as of Tuesday, November 5, 2019. This trademark is owned by Pacific Pharmaceuticals Pte Ltd. The MEDIVIC trademark is filed in the Pharmaceutical Products category with the following description:

Mineral dietary supplements for humans; pharmaceutical drugs, namely, antipyretics, anti-infectives, antineoplastics, diuretics, and pharmaceutical preparations for the treatment of immune system disorders, disorders of the central nervous system, endocrine disorders, gastrointestinal diseases, dermatological diseases, infectious diseases, cardiovascular diseases, and respiratory diseases
medivic

General Information


Serial Number79249332
Word MarkMEDIVIC
Filing DateWednesday, October 3, 2018
Status700 - REGISTERED
Status DateTuesday, November 5, 2019
Registration Number5899667
Registration DateTuesday, November 5, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 20, 2019

Trademark Statements


Goods and ServicesMineral dietary supplements for humans; pharmaceutical drugs, namely, antipyretics, anti-infectives, antineoplastics, diuretics, and pharmaceutical preparations for the treatment of immune system disorders, disorders of the central nervous system, endocrine disorders, gastrointestinal diseases, dermatological diseases, infectious diseases, cardiovascular diseases, and respiratory diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 15, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePacific Pharmaceuticals Pte Ltd
Party Type30 - Original Registrant
Legal Entity Type24 - NOT AVAILABLE
AddressSG

Party NamePacific Pharmaceuticals Pte Ltd
Party Type20 - Owner at Publication
Legal Entity Type24 - NOT AVAILABLE
AddressSG

Party NamePacific Pharmaceuticals Pte Ltd
Party Type10 - Original Applicant
Legal Entity Type24 - NOT AVAILABLE
AddressSG

Trademark Events


Event DateEvent Description
Saturday, March 21, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, March 4, 2020FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, March 4, 2020FINAL DISPOSITION PROCESSED
Wednesday, February 5, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 5, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, August 20, 2019PUBLISHED FOR OPPOSITION
Friday, August 16, 2019NOTIFICATION PROCESSED BY IB
Wednesday, July 31, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 31, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 31, 2019NOTICE OF PUBLICATION
Thursday, July 18, 2019ASSIGNED TO LIE
Wednesday, July 10, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 10, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 9, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 9, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, February 16, 2019REFUSAL PROCESSED BY IB
Thursday, January 31, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, January 31, 2019REFUSAL PROCESSED BY MPU
Saturday, January 19, 2019APPLICATION FILING RECEIPT MAILED
Friday, January 18, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, January 17, 2019NON-FINAL ACTION WRITTEN
Tuesday, January 15, 2019ASSIGNED TO EXAMINER
Tuesday, January 15, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 10, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB